Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
Twist Bioscience (NASDAQ: TWST), a mid-cap life sciences company in the healthcare sector, has announced its financial results for the first quarter of fiscal 2025, which ended December 31, 2024. The company has scheduled a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss the results and provide a business update.
Participants interested in joining via telephone must register through the company's Investor Relations website. Detailed earnings report and investor presentation are available on the Events and Presentations page of Twist Bioscience's website. A webcast replay will be accessible for two weeks following the call.
Twist Bioscience (NASDAQ: TWST), una società di medie dimensioni operante nel settore delle scienze della vita, ha annunciato i risultati finanziari per il primo trimestre dell'anno fiscale 2025, che si è concluso il 31 dicembre 2024. L'azienda ha programmato una conference call e una trasmissione audio in diretta per analisti e investitori alle 8:00 ora orientale, per discutere i risultati e fornire un aggiornamento aziendale.
I partecipanti interessati a unirsi tramite telefono devono registrarsi sul sito web delle Relazioni con gli Investitori dell'azienda. Il report dettagliato sui guadagni e la presentazione per gli investitori sono disponibili nella pagina Eventi e Presentazioni del sito web di Twist Bioscience. Una registrazione della trasmissione sarà accessibile per due settimane dopo la chiamata.
Twist Bioscience (NASDAQ: TWST), una empresa de mediana capitalización en el sector de las ciencias de la vida, ha anunciado sus resultados financieros para el primer trimestre del año fiscal 2025, que finalizó el 31 de diciembre de 2024. La compañía ha programado una llamada en conferencia y una transmisión de audio en vivo para analistas e inversores a las 8:00 a.m. hora del Este, para discutir los resultados y proporcionar una actualización comercial.
Los participantes interesados en unirse por teléfono deberán registrarse a través del sitio web de Relaciones con Inversores de la empresa. El informe detallado de ganancias y la presentación para inversores están disponibles en la página de Eventos y Presentaciones del sitio web de Twist Bioscience. Una repetición de la transmisión estará disponible durante dos semanas después de la llamada.
트위스트 바이오사이언스 (NASDAQ: TWST)는 생명 과학 부문의 중형 기업으로, 2024년 12월 31일에 끝난 2025 회계연도 1분기 재무 결과를 발표했습니다. 회사는 동부 시간 기준 오전 8시에 분석가 및 투자자와 결과를 논의하고 비즈니스 업데이트를 제공하기 위한 컨퍼런스 콜 및 실시간 오디오 웹캐스트를 예정했습니다.
전화로 참여하고자 하는 참가자는 회사의 투자자 관계 웹사이트를 통해 등록해야 합니다. 자세한 수익 보고서 및 투자자 프레젠테이션은 트위스트 바이오사이언스 웹사이트의 이벤트 및 프레젠테이션 페이지에서 확인할 수 있습니다. 웹캐스트 재생은 통화 후 2주 동안 액세스할 수 있습니다.
Twist Bioscience (NASDAQ: TWST), une entreprise de taille intermédiaire dans le secteur des sciences de la vie, a annoncé ses résultats financiers pour le premier trimestre de l'exercice fiscal 2025, qui s'est terminé le 31 décembre 2024. La société a programmé une conférence téléphonique et un webinaire audio en direct à 8h00, heure de l'Est, pour discuter des résultats et fournir une mise à jour sur les affaires.
Les participants souhaitant rejoindre par téléphone doivent s'inscrire via le site des Relations avec les Investisseurs de l'entreprise. Un rapport détaillé sur les bénéfices et une présentation pour les investisseurs sont disponibles sur la page Événements et Présentations du site de Twist Bioscience. Un replay du webinaire sera accessible pendant deux semaines après l'appel.
Twist Bioscience (NASDAQ: TWST), ein Unternehmen der Mid-Cap-Größe im Bereich Biowissenschaften, hat seine Finanzergebnisse für das erste Quartal des Geschäftsjahres 2025 bekannt gegeben, das am 31. Dezember 2024 endete. Das Unternehmen hat eine Telefonkonferenz und eine Live-Audio-Webcast für Analysten und Investoren um 8:00 Uhr Eastern Time angesetzt, um die Ergebnisse zu diskutieren und ein Update zur Geschäftslage zu geben.
Teilnehmer, die per Telefon teilnehmen möchten, müssen sich über die Investor-Relations-Website des Unternehmens registrieren. Detaillierte Finanzberichte und Investor-Präsentationen sind auf der Seite „Veranstaltungen und Präsentationen“ der Website von Twist Bioscience verfügbar. Eine Aufzeichnung des Webcasts wird zwei Wochen nach dem Anruf zugänglich sein.
- None.
- None.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal first quarter 2025 earnings report and the investor presentation, or click https://investors.twistbioscience.com/events-and-presentations.
The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company’s business. The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram | Bluesky
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203733194/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When did Twist Bioscience (TWST) release its Q1 2025 earnings?
How can investors access TWST's Q1 2025 earnings call?
Where can investors find TWST's Q1 2025 earnings presentation?
How long will TWST's Q1 2025 earnings webcast replay be available?
